Revascularization and Medical Therapy in Ischemic Ventricular Dysfunction: Implications and Viability Assessment

Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD.

Related Content:

• Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
• Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive